A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States

[1] Kolodny A(2015)The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction Annu Rev Public Health 36 559-574

[2] Courtwright DT(2012)Opioid epidemic in the United States Pain Physician 15 ES9-ES38

[3] Hwang CS(2011)The prescription drug epidemic in the United States: a perfect storm Drug Alcohol Rev. 30 264-270

[4] Kreiner P(2015)Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs N Engl J Med 372 2118-2126

[5] Eadie JL(2014)Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines--United States, 2012 MMWR Morb Mortal Wkly Rep 63 563-568

[6] Clark TW(2009)The promotion and marketing of OxyContin: commercial triumph, public health tragedy Am J Public Health 99 221-227

[7] Alexander GC(2012)Rethinking opioid prescribing to protect patient safety and public health JAMA 308 1865-1866

[8] Manchikanti L(1996)APS 1995 presidential address Pain Forum 5 85-88

[9] Helm S(2013)Pain as the 5th vital sign: exposing the vital need for pain education Clin Ther 35 1728-1732

[10] Fellows B(2015)A systematic review of risk and protective factors associated with nonmedical use of prescription drugs among youth in the United States: a social ecological perspective J Stud Alcohol Drugs 76 5-20

[1] Kolodny A(2015)The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction Annu Rev Public Health 36 559-574

[2] Courtwright DT(2012)Opioid epidemic in the United States Pain Physician 15 ES9-ES38

[3] Hwang CS(2011)The prescription drug epidemic in the United States: a perfect storm Drug Alcohol Rev. 30 264-270

[4] Kreiner P(2015)Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs N Engl J Med 372 2118-2126

[5] Eadie JL(2014)Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines--United States, 2012 MMWR Morb Mortal Wkly Rep 63 563-568

[6] Clark TW(2009)The promotion and marketing of OxyContin: commercial triumph, public health tragedy Am J Public Health 99 221-227

[7] Alexander GC(2012)Rethinking opioid prescribing to protect patient safety and public health JAMA 308 1865-1866

[8] Manchikanti L(1996)APS 1995 presidential address Pain Forum 5 85-88

[9] Helm S(2013)Pain as the 5th vital sign: exposing the vital need for pain education Clin Ther 35 1728-1732

[10] Fellows B(2015)A systematic review of risk and protective factors associated with nonmedical use of prescription drugs among youth in the United States: a social ecological perspective J Stud Alcohol Drugs 76 5-20